PEP PHARMA
Timeline
28 events since 2010Board
Capital
Filings
Financial
Establishments
Address
201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 22 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0827545996
Annual accounts 2024 filed PDFfull format · 14 days before the deadline
2024
Highest result from 2011 to 2025 net €491,572 ▲99.8% The operating result of €508,807 and the net result of €491,572 are both a record.
Annual accounts 2023 filed PDFfull format · 5 days before the deadline
2023
Registered office moved to PEPINSTER Rue Hubert HaletNew registered office: 4860 PEPINSTER Rue Hubert Halet 5A/0 · Appointments: (director) and (director) · Permanent representative: · General meeting of 23-08-20237 points ▸
- General meeting, 23-08-2023
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- Purpose change, “La société aura également pour objet la constitution pour son propre compte d'un patrimoine immobilier,la gestion de biens immobiliers dont elle est ou…” (deed in French)
- Director appointment,
- Permanent representative,
- Director appointment,
- Registered-office move, 4860 PEPINSTER Rue Hubert Halet 5A/0
- The deed holds 7 more points.
Annual accounts 2022 filed PDFfull format · 29 days late
2022
Back to profit net €323,338 The net result is €323,338, after one loss-making year.
Equity above €500,000 equity €594,033 ▲119% Equity rises from €270,695 to €594,033.
Annual accounts 2021 filed PDFfull format · 31 days late
2021
Weakest financial year net -€98,913 The net result drops to -€98,913, the lowest from 2011 to 2025. It recovers the following year.
Annual accounts 2020 filed PDFfull format · 61 days late
2020
Annual accounts 2019 filed PDFfull format · 98 days late
2019
Annual accounts 2018 filed PDFfull format · 30 days late
2018
Equity above €200,000 equity €351,335 ▲232% After 4 profitable years in a row, equity reaches €351,335.
2 managers appointed, 1 resignationAppointments: (manager) and (manager) · Permanent representative: · Resignation: (manager) · General meeting of 28-06-20185 points ▸
- General meeting, 28-06-2018
- Director appointment, (manager)
- Permanent representative,
- Director appointment, (manager)
- Director resignation, (manager)
Annual accounts 2017 filed PDFfull format · 56 days late
Capital increase of €234,000 to €254,000Capital from €20,000 to €254,000, 78 new shares · holds 78 shares · holds 78 shares · General meeting of 04-04-20188 points ▸
- General meeting, 04-04-2018
- Auditor report, 09-02-2018
- Capital increase, €234,000
- holds 78 shares
- holds 78 shares
- Capital, €254,000, 278 shares
- Amendment of the articles, article 5
- Amendment of the articles, article 6
- The deed holds 8 more points.
2017
Equity above €100,000 equity €105,711 ▲71.1% After 3 profitable years in a row, equity reaches €105,711.
Annual accounts 2016 filed PDFfull format · 29 days late
2016
Annual accounts 2015 filed PDFfull format · 29 days late
2015
Back to profit net €10,262 The net result is €10,262, after 2 loss-making years.
Annual accounts 2014 filed PDFfull format · 28 days late
2014
Annual accounts 2013 filed PDFfull format · 37 days before the deadline
2013
Annual accounts 2012 filed PDFfull format · 27 days late
2012
Annual accounts 2011 filed PDFfull format · 29 days late
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank